Table 3 The LARS in SER and non-SER group after discharge
From: Self-administered succus entericus reinfusion before ileostomy closure improves short-term outcomes
SER group (n = 30) | Non-SER group (n = 42) | p value | |
|---|---|---|---|
1 week after discharge | 0.034 | ||
No LARS (0–20) | 14 | 11 | |
Minor LARS (21–29) | 11 | 12 | |
Major LARS (30–42) | 5 | 19 | |
1 month after discharge | 0.220 | ||
No LARS (0–20) | 13 | 14 | |
Minor LARS (21–29) | 13 | 15 | |
Major LARS (30–42) | 4 | 13 |